Trial Report REGENECYTE cord blood cell therapy in post-COVID syndrome: a phase IIa randomized, placebo-controlled trial, 2026, Huang et al

No—Topol is actually (shockingly) being good/helpful here. He is criticizing Attia for hawking this bogus AG-1 supplement and these David protein bars, etc.

“Moreover, these days you are riddled with conflicts as a huckster for David Bars, AG-1 supplement, and so many other things that diminish your credibility. That's a shame.”
 
I think we have to appreciate that in the last ten to twenty years, in some parts of the world, very much including the USA, any formal distinction between medical science and either crackpot ventures, or fraud, or both has disappeared. Things have changed out of all recognition. Just as people have talked of countries becoming banana republics we now have banana medicine.

In amongst that there are units delivering treeatments based on excellent science and reliable clinical evidence but even in the UK I sense my colleagues involved in medicine are beginning to lose the will to do things properly. At least for the moment populism has won.
Same pattern everywhere. Venture capital firms typically fund hundreds of startups, most fail, the few that make it are profitable enough that all the losses are worth it. Same with pharmaceutical trials. Research is mostly a brute force thing, outside of a few exceptions. Problem is that fact isn't accepted, what is mostly chance is usually framed as 'lone genius' kind of thing, when in fact it's mostly lottery winner stuff.

If the fact were accepted, it would completely change how so-called evidence-based medicine functions, but the process is mistaken for the goal, and the goal mistaken for the process. The easy stuff has been figured out, the rest requires hard work and it's not happening because so many people hold on to this mistaken idea of how breakthroughs happen.
 
Back
Top